Recently, Kubli et al. described that FcμR negatively regulated anti-tumor activity by tumor-associated mononuclear phagocytes (TMPs) in a melanoma mouse model using the Fcmr KO-M strain. This evidence concerns the gene FCMR and neoplasm.